X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (252) 252
humans (233) 233
long-acting octreotide (110) 110
male (109) 109
female (106) 106
octreotide (94) 94
somatostatin - analogs & derivatives (91) 91
middle aged (90) 90
octreotide - therapeutic use (82) 82
adult (81) 81
endocrinology & metabolism (75) 75
somatostatin (66) 66
oncology (64) 64
somatostatin - therapeutic use (63) 63
acromegaly (58) 58
aged (57) 57
long-acting somatostatin (57) 57
pharmacology & pharmacy (54) 54
treatment outcome (52) 52
acromegaly - drug therapy (51) 51
long-acting formulation (51) 51
gastroenterology & hepatology (50) 50
somatostatin analogs (48) 48
management (45) 45
lanreotide (43) 43
medicine & public health (41) 41
therapy (41) 41
antineoplastic agents - therapeutic use (40) 40
animals (38) 38
efficacy (38) 38
care and treatment (37) 37
cancer (36) 36
peptides, cyclic - therapeutic use (36) 36
hepatocellular carcinoma (34) 34
octreotide - administration & dosage (34) 34
somatostatin - administration & dosage (34) 34
antineoplastic agents, hormonal - therapeutic use (33) 33
follow-up (33) 33
neuroendocrine tumors (31) 31
growth-hormone (30) 30
liver neoplasms - drug therapy (30) 30
neuroendocrine tumors - drug therapy (30) 30
tumors (30) 30
carcinoma, hepatocellular - drug therapy (28) 28
quality of life (28) 28
expression (26) 26
medicine, general & internal (26) 26
peptides, cyclic - administration & dosage (25) 25
clinical trials (24) 24
health aspects (24) 24
research (24) 24
somatostatin - adverse effects (24) 24
delayed-action preparations (23) 23
long-acting release (23) 23
octreotide - adverse effects (23) 23
surgery (22) 22
abridged index medicus (21) 21
internal medicine (21) 21
pancreatic neoplasms - drug therapy (21) 21
placebo (21) 21
aged, 80 and over (20) 20
chemotherapy (20) 20
diabetes (20) 20
polycystic kidney disease (20) 20
randomized controlled-trial (20) 20
term treatment (20) 20
analysis (19) 19
growth hormone (19) 19
growth-factor-i (19) 19
injections, subcutaneous (19) 19
octreotide lar (19) 19
peptides, cyclic - adverse effects (19) 19
somatostatin analog (19) 19
drug therapy (18) 18
endocrinology (18) 18
diagnosis (17) 17
igf-i (17) 17
liver-disease (17) 17
randomized controlled trials as topic (17) 17
slow-release lanreotide (17) 17
somatostatin receptors (17) 17
adolescent (16) 16
carcinoma, hepatocellular - pathology (16) 16
insulin-like growth factor i - metabolism (16) 16
pharmacokinetics (16) 16
prognosis (16) 16
somatostatin analogues (16) 16
acromegalic patients (15) 15
analogs (15) 15
disease progression (15) 15
everolimus (15) 15
liver cancer (15) 15
liver neoplasms - pathology (15) 15
pituitary neoplasms - drug therapy (15) 15
pituitary-adenomas (15) 15
polycystic kidney, autosomal dominant - drug therapy (15) 15
secreting pituitary-adenomas (15) 15
dose-response relationship, drug (14) 14
hepatoma (14) 14
lar (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
PLoS medicine, ISSN 1549-1277, 04/2019, Volume 16, Issue 4, pp. e1002777 - e1002777
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2010, Volume 102, Issue 8, pp. 547 - 556
Journal Article
Endocrine Journal, ISSN 0918-8959, 2013, Volume 60, Issue 8, pp. 951 - 957
A 73-year-old woman with malignant insulinoma was treated with 100 μg/day octreotide for unresected insulinoma and liver metastases. The daily administration... 
Octreotide long-acting repeatable | Octreotide | Hyperglycemia | Hypoglycemia | Insulinoma | MANAGEMENT | FUNCTIONING INSULINOMA | ANALOGS | HYPOGLYCEMIC DISORDERS | ADULTS | ZOLLINGER-ELLISON-SYNDROME | TUMORS | FEATURES | SOMATOSTATIN | ENDOCRINOLOGY & METABOLISM | Index Medicus
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 01/2015, Volume 60, Issue 1, pp. 48 - 53
BACKGROUND AND AIMS:Octreotide reduces splanchnic blood flow and is effective in controlling gastrointestinal bleeding (GIB) caused by portal hypertension.... 
portal hypertension | octreotide | depot octreotide | children | longacting octreotide | gastrointestinal bleeding | WIRELESS CAPSULE ENDOSCOPY | EFFICACY | ANGIODYSPLASIA | VARICEAL HEMORRHAGE | NUTRITION & DIETETICS | SOMATOSTATIN ANALOG | THERAPY | PEDIATRIC-PATIENTS | long-acting octreotide | PEDIATRICS | LAR | GASTROENTEROLOGY & HEPATOLOGY | DIAGNOSTIC YIELD | PORTAL-HYPERTENSION | Recurrence | Hypertension, Portal - physiopathology | Follow-Up Studies | Humans | Gastrointestinal Agents - administration & dosage | Child, Preschool | Infant | Male | Gastrointestinal Hemorrhage - epidemiology | Portal Vein | Delayed-Action Preparations - administration & dosage | Dose-Response Relationship, Drug | Gastrointestinal Hemorrhage - therapy | Female | Retrospective Studies | Octreotide - administration & dosage | Child | Severity of Illness Index | Thrombosis - physiopathology | Tertiary Care Centers | Octreotide - adverse effects | Octreotide - therapeutic use | Hypertension, Portal - drug therapy | Gastrointestinal Hemorrhage - prevention & control | Pilot Projects | Delayed-Action Preparations - adverse effects | Gastrointestinal Hemorrhage - etiology | Adolescent | Gastrointestinal Agents - therapeutic use | Delayed-Action Preparations - therapeutic use | Gastrointestinal Agents - adverse effects | Thrombosis - drug therapy | London - epidemiology | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9903, pp. 1485 - 1495
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2010, Volume 66, Issue 5, pp. 837 - 844
Journal Article